Pre-operative, peri-operative, and post-operative analgesic anti-inflammatory treatment is the optimal goal in treating surgical patients. Liposomal JD-005 in intravenous and oral formulations achieves this goal.
Up to 6% of patients undergoing a surgical procedure develop an opioid addiction. Use of a non opioid, non NSAID, in combination with an acetaminophen based approach or by itself, can be given pre, peri and post operatively in a very novel approach to reduce the amount of opioids needed in the recovery from all operations. The lack of any bleeding risks from our compound makes its use in the operating room and post operative setting a very attractive alternative to the current “multi-modal” treatment of surgical pain.